160 related articles for article (PubMed ID: 35564662)
21. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
22. Screening for chronic kidney disease of uncertain aetiology in Sri Lanka: usability of surrogate biomarkers over dipstick proteinuria.
Ratnayake S; Badurdeen Z; Nanayakkara N; Abeysekara T; Ratnatunga N; Kumarasiri R
BMC Nephrol; 2017 Jun; 18(1):199. PubMed ID: 28629425
[TBL] [Abstract][Full Text] [Related]
23. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
25. The Utility of Novel Renal Biomarkers in Assessment of Chronic Kidney Disease of Unknown Etiology (CKDu): A Review.
Gunasekara TDKSC; De Silva PMCS; Herath C; Siribaddana S; Siribaddana N; Jayasumana C; Jayasinghe S; Cardenas-Gonzalez M; Jayasundara N
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33353238
[TBL] [Abstract][Full Text] [Related]
26. Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries.
Elmedany SM; Naga SS; Elsharkawy R; Mahrous RS; Elnaggar AI
J Crit Care; 2017 Aug; 40():171-177. PubMed ID: 28411423
[TBL] [Abstract][Full Text] [Related]
27. Value of urine IL-8, NGAL and KIM-1 for the early diagnosis of acute kidney injury in patients with ureteroscopic lithotripsy related urosepsis.
Tan D; Zhao L; Peng W; Wu FH; Zhang GB; Yang B; Huo WQ
Chin J Traumatol; 2022 Jan; 25(1):27-31. PubMed ID: 34702632
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN).
Liao B; Nian W; Xi A; Zheng M
Med Sci Monit; 2019 Jan; 25():565-570. PubMed ID: 30659575
[TBL] [Abstract][Full Text] [Related]
29. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients.
Ranasinghe AV; Kumara GWGP; Karunarathna RH; De Silva AP; Sachintani KGD; Gunawardena JMCN; Kumari SKCR; Sarjana MSF; Chandraguptha JS; De Silva MVC
BMC Nephrol; 2019 Aug; 20(1):338. PubMed ID: 31462219
[TBL] [Abstract][Full Text] [Related]
30. Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children.
Assadi F; Sharbaf FG
Pediatr Emerg Care; 2019 Feb; 35(2):104-107. PubMed ID: 27741065
[TBL] [Abstract][Full Text] [Related]
31. Can Urinary KIM-1 and NGAL Predict Management Endoscopic Surgery in Acute Unilateral Obstructive Stone Disease? Results from a Prospective Cohort Study.
Göger YE; Özkent MS; Topçu C; Atıcı A; Sönmez MG; Balasar M; Gürbilek M
Urol Int; 2022; 106(5):446-454. PubMed ID: 34333489
[TBL] [Abstract][Full Text] [Related]
32. Role of urinary NGAL and KIM-1 as biomarkers of early kidney injury in obese prepubertal children.
Polidori N; Giannini C; Salvatore R; Pelliccia P; Parisi A; Chiarelli F; Mohn A
J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1183-1189. PubMed ID: 32845866
[TBL] [Abstract][Full Text] [Related]
33. Can serum Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 help in decision making for surgery in antenatally dedected hydronephrosis.
Yiğit D; Taşkınlar H; Avlan D
J Pediatr Urol; 2021 Feb; 17(1):71.e1-71.e7. PubMed ID: 33139211
[TBL] [Abstract][Full Text] [Related]
34. Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?
Özkuvancı Ü; Dönmez Mİ; Ziylan O; Oktar T; Küçükgergin C; Çetin B; Erdem S; Seçkin Ş
J Pediatr Urol; 2020 Dec; 16(6):844.e1-844.e7. PubMed ID: 32988771
[TBL] [Abstract][Full Text] [Related]
35. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
36. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
37. Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis.
Ding Y; Nie LM; Pang Y; Wu WJ; Tan Y; Yu F; Zhao MH
Lupus; 2018 Oct; 27(11):1778-1789. PubMed ID: 30020021
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
Bhavsar NA; Köttgen A; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
[TBL] [Abstract][Full Text] [Related]
39. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A
Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
[TBL] [Abstract][Full Text] [Related]
40. Urinary NGAL is a Potential Biomarker for Early Renal Injury in Insulin Resistant Obese Non-diabetic Children.
Şen S; Özalp Kızılay D; Taneli F; Özen Ç; Ertan P; Özunan İ; Yıldız R; Ersoy B
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):400-407. PubMed ID: 34013756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
